Publication | Closed Access

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Genetic EpidemiologyImmunologyPathologyCirrhosisAutoimmune Liver DiseaseImmune PathogenesisHepatic DisordersHepatotoxicityAutoimmune DiseaseLiver PhysiologyAutoimmunityDrug-induced Liver InjuryInborn Error Of ImmunityHepatologyHepatitisAcute Liver FailureLiver DiseaseMedicineGenome-wide Pharmacogenetic InvestigationHepatic Adverse Event